statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	956
SG - Singapore	250
CN - Cina	142
DE - Germania	64
BR - Brasile	56
VN - Vietnam	54
IT - Italia	41
HK - Hong Kong	39
UA - Ucraina	37
GB - Regno Unito	34
TR - Turchia	22
FI - Finlandia	18
FR - Francia	17
CA - Canada	14
MX - Messico	14
SE - Svezia	14
IN - India	11
JP - Giappone	11
RU - Federazione Russa	9
BD - Bangladesh	8
AR - Argentina	7
BE - Belgio	6
ES - Italia	5
ZA - Sudafrica	4
IR - Iran	3
PK - Pakistan	3
PL - Polonia	3
AZ - Azerbaigian	2
CO - Colombia	2
EC - Ecuador	2
JO - Giordania	2
PA - Panama	2
PH - Filippine	2
SA - Arabia Saudita	2
SI - Slovenia	2
AE - Emirati Arabi Uniti	1
AF - Afghanistan, Repubblica islamica di	1
AO - Angola	1
AT - Austria	1
BW - Botswana	1
CH - Svizzera	1
CL - Cile	1
CZ - Repubblica Ceca	1
EG - Egitto	1
HN - Honduras	1
ID - Indonesia	1
IE - Irlanda	1
IQ - Iraq	1
JM - Giamaica	1
KE - Kenya	1
KW - Kuwait	1
LB - Libano	1
LT - Lituania	1
MT - Malta	1
MU - Mauritius	1
MY - Malesia	1
NP - Nepal	1
PE - Perù	1
PS - Palestinian Territory	1
PT - Portogallo	1
PY - Paraguay	1
RO - Romania	1
UY - Uruguay	1
VE - Venezuela	1
Totale	1.887

Nome	#
A non-invasive method for the in vivo determination of skin antioxidant capacity	299
Novel selective human mitochondrial kinase inhibitors: Design, synthesis and enzymatic activity	228
Hindered nucleoside analogs as antiflaviviridae agents	209
Design, Synthesis and Anti Flaviviridae Activity of N 6-, 5,3-O- and 5,2-O-Substituted Adenine Nucleoside Analogs	199
Design, synthesis and binding at cloned muscarinic receptors of N-[5-(1'-substituted-acetoxymethyl)-3-oxadiazolyl] and N-[4-(1'-substituted-acetoxymethyl)-2-dioxolanyl] dialkyl amines	185
Design, Synthesis and activity of a new series of nucleoside analogues displaying potent antiflaviviridae activity.	165
Determinazione dell'efficacia antiossidante di formulazioni cosmetiche attraverso metodiche non invasive	153
Adenosine phosphonoacetic acid is slowly metabolized by NDP kinase	116
The characterization of human adenylate kinases 7 and 8 demonstrates differences in kinetic parameters and structural organization among the family of adenylate kinase isoenzymes	95
Ribonucleotide reductase potential inhibitors: Design, synthesis and activity of bioisosters of ribofuranosylnucleoside diphosphates	88
null	88
Synthesis, modeling and evaluation of 3'-(1-aryl-1H-tetrazol-5-ylamino)-substituted 3'-deoxythymidine derivatives as potent and selective human mitochondrial thymidine kinase inhibitors	71
Totale	1.896

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	20	0	0	0	0	0	0	0	0	0	0	16	4
2021/2022	101	2	3	15	5	6	4	6	1	4	7	10	38
2022/2023	113	9	6	4	17	23	19	10	4	14	0	6	1
2023/2024	55	7	11	5	0	7	6	0	2	6	0	1	10
2024/2025	320	7	8	24	24	38	58	16	10	30	21	49	35
2025/2026	783	80	22	46	136	165	66	85	31	77	69	6	0
Totale													1.896

SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara